Pulmonary Pharmacology & Therapeutics

Papers
(The median citation count of Pulmonary Pharmacology & Therapeutics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis78
Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers47
Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy – CONTROL study38
Shedding light on vitamin D in tuberculosis: A comprehensive review of clinical trials and discrepancies36
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)32
Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin d27
The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells27
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients27
S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function22
Pharmacokinetic variability of CFTR modulators from standard and alternative regimens22
Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential21
Editorial Board21
Editorial Board21
Editorial Board19
Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis19
Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets19
The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study16
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes16
Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma16
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study16
Ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced acute lung injury14
Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: Simvastatin as a potential adjuvant in cellular homing14
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis13
Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea12
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts12
A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects12
Unveiling the protective role of sevoflurane in video-assisted thoracoscopic surgery associated-acute lung injury: Inhibition of ferroptosis12
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial12
Efficacy and safety of sequential combination therapy for pulmonary arterial hypertension: A meta-analysis of Randomized-Controlled Trials11
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score11
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant11
Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice11
Impact on beclometasone dipropionate pharmacokinetics when switching to a low global warming potential propellant in a pressurised metered-dose inhaler11
Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis10
Editorial Board10
The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study10
Editorial Board10
Ensifentrine approval: A milestone in the treatment of COPD10
Editorial Board10
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study9
Corrigendum to “Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients 9
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma9
Scoping review: The state of research on cryptogenic organizing pneumonia therapeutics9
Editorial Board9
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality8
Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea8
Strongyloides venezuelensis-derived venestatin ameliorates asthma pathogenesis by suppressing receptor for advanced glycation end-products-mediated signaling8
Protective effects of adipose-derived biogenic nanoparticles on the pulmonary microvascular endothelial barrier in mice with ventilator-induced lung injury via the TRPV4/ROCK1 signalling pathway8
The wonders of stem cells therapeutic application towards chronic obstructive pulmonary disease8
Remote preconditioning combined with nebulized budesonide alleviate lipopolysaccharide induced acute lung injury via regulating HO-1 and NF-κB in rats8
Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-α8
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study8
Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany7
β-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthma7
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-197
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma7
Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma7
Safety and tolerability of inhaled antibiotics in patients with bronchiectasis7
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan7
Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study7
Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats7
The immunomodulatory effects of macrolide antibiotics in respiratory disease6
HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB36
Tyvaso DPI: Drug-device characteristics and patient clinical considerations6
ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway6
Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities6
Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis6
Editorial Board6
Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics6
Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia6
Activating transcription factor 6 in the endothelial context6
The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis6
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience6
Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma5
Pulmonary drug delivery for acute respiratory distress syndrome5
Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPα expression5
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination5
Editorial Board5
Which LABA/LAMA should be chosen in COPD patients in real life?5
Corrigendum to “Bleomycin induced lung fibrosis increases work of breathing in the mouse” [Pulm. Pharmacol.Therapeut. 25 (2012) 281-285]5
Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate5
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting5
Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway5
SIRT3 alleviates sepsis-induced acute lung injury by inhibiting pyroptosis via regulating the deacetylation of FoxO3a5
Medication use in people with cystic fibrosis before and after modulator therapy5
Comparative biochemical efficacy analysis of an alpha1-proteinase inhibitor (Glassia®) in patients with alpha-1 antitrypsin deficiency5
Effect of roflumilast on airway remodeling in asthmatic mice exposed to or not exposed to cigarette smoke: Comparison with the effect of dexamethasone4
Dexmedetomidine reduces IL-4 and IgE expression through downregulation of theTLR4/NF-κB signaling pathway to alleviate airway hyperresponsiveness in OVA mice4
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension4
Effect of centrally and peripherally acting GABAB agonism on the healthy human cough reflex4
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis4
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-194
Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis4
Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial4
The compound artemisinin-hydroxychloroquine ameliorates bleomycin-induced pulmonary fibrosis in rats by inhibiting TGF-β1/Smad2/3 signaling pathway4
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat4
Corrigendum to “Presence and function of β-adrenergic receptors in primary equine bronchial epithelia cells” [Pulm Pharmacol Ther. (2020 Apr) 61 101897] DOI: 10.1016/j.pupt.2020.1018974
Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients4
Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis4
Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress4
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia4
Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL34
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study4
0.19328212738037